quinoxalines has been researched along with Papillomavirus Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, C; Gandhi, N; Grant, NN; Halmos, B; Kim, C; Krochmal, R; Liu, SV; Reuss, JE; Sackstein, P; Yeung, V | 1 |
1 other study(ies) available for quinoxalines and Papillomavirus Infections
| Article | Year |
|---|---|
Use of Erdafitinib in
Topics: Humans; Papillomavirus Infections; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 3; Respiratory Tract Infections | 2022 |